• Best Wishes to all for a Wonderful, Joyous & Beautiful Holiday Season, and a Joyful New Year!

Trump pumps Kodak

Kodak is moving into pharmaceutical manufacturing, but "remain 100% committed to print and will continue to invest in ground-breaking innovations, especially in digital print. Print will be an important revenue source as the new pharmaceutical business gets up to speed.” ~Kodak executive chairman Jim Continenza

Lol, sounds to me 'print is going away so we need a new source of revenue.'
 
Here's a link to watch Trump make the announcement:


Apparently Hydroquinone - which is used in photo developer chemicals (Kodak is/was a supplier) can easily be converted into Hydroxychloroquine (generic Plaquenil) - Trump's drug of choice against Covid 19 despite the CDC's (Fauci's) and other medical bodies' objections.

Interestingly that's on top of Trump's May announcement of a four-year, $354 million contract with a fledgling company, Phlow Corporation, to build a generic medicine and API plant in Richmond, Virginia. That deal, awarded by the Department of Health and Human Services' Biomedical Advanced Research and Development Authority, could be expanded up to 10 years to a total of $812 million.
(source: Trump to Tap New Company to Make Covid-19 Drugs in the U.S.)

I wonder what the traditional drug manufacturers think of all this?
I wonder what the SEC thinks of all this. Insider trading bonanza? Apparently Kodak Chairman Jim Continenza bought 46,737 shares of Kodak stock on June 23 at an average price of $2.22. Roughly a month later, that $103,575 investment is now worth more than $1.5 million
 
Last edited:
gordo said:
I wonder what the traditional drug manufacturers think of all this?
I wonder what the SEC thinks of all this. Insider trading bonanza? Apparently Kodak Chairman Jim Continenza bought 46,737 shares of Kodak stock on June 23 at an average price of $2.22. Roughly a month later, that $103,575 investment is now worth more than $1.5 million
Click to expand...
Hah. That's not even the half of it. The average trading volume for the DAY before the announcement was up 20x average daily trading volumes. I hope they get slapped shitless. This stinks of insider trading.
 
PricelineNegotiator said:
Hah. That's not even the half of it. The average trading volume for the DAY before the announcement was up 20x average daily trading volumes. I hope they get slapped. This stinks of insider trading.
Click to expand...
Not sure if accurate but I saw this online.
IMG_2138.PNG
 
Last edited by a moderator:
PricelineNegotiator said:

It helps if you look a little bit harder. That graph you posted is not correct.
Click to expand...

Would you say the tall bar is roughly 20x taller than the previous shorter bar? If so, the graph is accurate - according to the CNBC article you posted anyway: "On Monday, prior to the announcement, 1,645,719 shares traded hands in the stock, far surpassing Friday’s 74,893 trades, and Thursday’s 80,840 trades . . .over the last year the average daily trading volume has been 236,479, according to FactSet."
 
Volume of shares traded does not correlate to the value of the stock increasing or decreasing. Compare the Yahoo graph to his. They aren't even the same data points...
 
kansasquaker said:
Would you say the tall bar is roughly 20x taller than the previous shorter bar? If so, the graph is accurate - according to the CNBC article you posted anyway: "On Monday, prior to the announcement, 1,645,719 shares traded hands in the stock, far surpassing Friday’s 74,893 trades, and Thursday’s 80,840 trades . . .over the last year the average daily trading volume has been 236,479, according to FactSet."
Click to expand...
I just read an article that high volume of shares being transferred was a deal struck between Kodak and Jim Continenza, where he was awarded 1.75 million shares as a bonus. Numbers still don't add up perfectly, but that surely accounts for the bump in traffic.
 
PricelineNegotiator said:
I just read an article that high volume of shares being transferred was a deal struck between Kodak and Jim Continenza, where he was awarded 1.75 million shares as a bonus. Numbers still don't add up perfectly, but that surely accounts for the bump in traffic.
Click to expand...
It looks like we'll find out. SEC is going to investigate. I think the 1.75 million shares were just options. I don't think that would show up in trade volume.

www.huffpost.com

SEC Investigating Kodak's Announcement Of $765 Million Government Loan: Report

The Wall Street Journal reported the news on Tuesday.
www.huffpost.com www.huffpost.com
 
kansasquaker said:
Kodak is moving into pharmaceutical manufacturing, but "remain 100% committed to print and will continue to invest in ground-breaking innovations, especially in digital print. Print will be an important revenue source as the new pharmaceutical business gets up to speed.” ~Kodak executive chairman Jim Continenza

Lol, sounds to me 'print is going away so we need a new source of revenue.'
Click to expand...
More like "we have successfully lost any market share we had left in the print industry through poor product management and archaic technology that was never advanced, so now we need to do something..."
 
PricelineNegotiator said:
www.cnn.com

Kodak stock soars after review finds no insider trading

Kodak stock briefly surged more than 80% on Wednesday after a special committee's investigation found no evidence of insider trading prior to the announcement of a US government loan.
www.cnn.com www.cnn.com
Click to expand...

Well...
"Although the review found no signs of Kodak breaking the law, it did find the company mishandled stock options granted to its CEO in the days leading up to the loan deal being signed."
"Kodak CEO Jim Continenza and other Kodak executives fell under scrutiny for receiving stock options the day before the loan's announcement on July 27."
"The review by Akin Gump concluded insider-trading laws were not violated,"
"However, the report did find Kodak at fault for the early disclosure of the government loan a day before it was officially announced, but not in violation of the laws."

It may not technically be "insider trading" however IMHO it still stinks of taking advantage of insider knowledge.
 
gordo said:
Well...
"Although the review found no signs of Kodak breaking the law, it did find the company mishandled stock options granted to its CEO in the days leading up to the loan deal being signed."
"Kodak CEO Jim Continenza and other Kodak executives fell under scrutiny for receiving stock options the day before the loan's announcement on July 27."
"The review by Akin Gump concluded insider-trading laws were not violated,"
"However, the report did find Kodak at fault for the early disclosure of the government loan a day before it was officially announced, but not in violation of the laws."

It may not technically be "insider trading" however IMHO it still stinks of taking advantage of insider knowledge.
Click to expand...
Agreed.
 
You must log in or register to reply here.

Similar threads

prwhite
Xitron Introduces New Offset Prepress Workflow at Drupa
Replies
1
Views
853
Martin Mueller
Martin Mueller
noelward
Do Vendors Know Anything?
Replies
0
Views
1739
noelward
noelward
noelward
Postpress Opportunities and More
Replies
0
Views
276
noelward
noelward
noelward
Growing Your Business
Replies
0
Views
588
noelward
noelward
noelward
drupa has little to do with print
Replies
3
Views
6707
joshlindsay
joshlindsay

PressWise

A 30-day Fix for Managed Chaos

As any print professional knows, printing can be managed chaos. Software that solves multiple problems and provides measurable and monetizable value has a direct impact on the bottom-line.

“We reduced order entry costs by about 40%.” Significant savings in a shop that turns about 500 jobs a month.

Learn how…….

   
Back
Top